Results 91 to 100 of about 37,026 (217)

Parasomnias and Antidepressant Therapy: A Review of the Literature [PDF]

, 2011
There exists a varying level of evidence linking the use of antidepressant medication to the parasomnias, ranging from larger, more comprehensive studies in the area of RBD to primarily case reports in the NREM parasomnias.
Lara Kierlin, Michael R. Littner
core   +2 more sources

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, EarlyView.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

Smoking cessation in severe mental ill health : what works? an updated systematic review and meta-analysis [PDF]

, 2017
BACKGROUND: People with severe mental ill health are more likely to smoke than those in the general population. It is therefore important that effective smoking cessation strategies are used to help people with severe mental ill health to stop smoking ...
A Baker, A Baker, AE Evins, AE Evins, AE Evins, AE Evins, AH Weinberger, AL Baker, B O'Brien, BS Wu, C Bullen, C McDonald, E Ratschen, E Weiner, E Weiner, Emily Peckham, Garry Tew, GW Dalack, HK Chen, J Hartmann-Boyce, JM Williams, JM Williams, JM Williams, JW Tidey, KN Chengappa, KR Fontaine, L Banham, Liz Cook, ML Steinberg, ML Steinberg, Q Wu, RC Smith, RM Anthenelli, S Brown, S Fatemi, S Gilbody, Sally Brabyn, SE Adkison, Simon Gilbody, SM Gallagher, TP George, TP George, TP George, VC Wing   +43 more
core   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Comparison of the effects of varenicline, bupropion and nicotine replacement therapy on smoking cessation program

Psychiatry and Clinical Psychopharmacology, 2021
Objective: The most effective aproach to individuals who wants to and decided to stop cigarettes smoking is behavior training with the application of motivational support and pharmacological therapy. This study aims to compare the effects of varenicline,
Selma Bozkurt Zincir, Esra Kaymak, Esra Aydın Sünbül, Nihat Zincir   +3 more
doaj  

Impact of Continuing Education on Clinicians' Self- Reported Knowledge of Tobacco Dependence and Tobacco Control Interventions [PDF]

, 2018
Purpose: To assess a tobacco cessation continuing education (CE) program for Indiana dental and medical providers. Methods: A 26-item immediate post-CE survey and a 19-item 3-month follow-up survey assessed changes in participants’ self-reported ...
Coan, Lorinda, Romito, Laura M.
core  

Design, recruitment, and retention of African-American smokers in a pharmacokinetic study [PDF]

, 2010
Background African-Americans remain underrepresented in clinical research despite experiencing a higher burden of disease compared to all other ethnic groups in the United States.
Babalola Faseru, Lisa S Cox, Carrie A Bronars, Isaac Opole, Gregory A Reed, Matthew S Mayo, Jasjit S Ahluwalia, Kolawole S Okuyemi, USDHHS, CDC, NL Roberson, RF Holcombe, GM Swanson, BP Dennis, B Evelyn, PA Ganz, AR Giuliano, TE King Jr, JH Powell, VL Shavers-Hornaday, N Stark, CK Svensson, W El-Sadr, LA Moyé, WK Nicholson, RB D'Agostino Sr, GJ Bonner, PB Gorelick, ED Paskett, SL Escobar-Chaves, G Corbie-Smith, G Corbie-Smith, CP Mouton, DB Stoy, RE Harris, K Okuyemi, CT Orleans, S Sidney, KM Cummings, KS Okuyemi, KS Okuyemi, KS Okuyemi, LS Cox, PA Cupertino, KJ Harris, JS Ahluwalia, JS Ahluwalia, JS Ahluwalia, MN Woods, JS Ahluwalia, KS Okuyemi, KS Okuyemi, FA Okah, KS Okuyemi, KJ Harris, NL Nollen, KS Okuyemi, LS Cox, KS Okuyemi, JS Ahluwalia, MN Woods, NL Nollen, D Brooks, GC Kabat   +63 more
core   +2 more sources

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Bupropion [PDF]

, 2017
David Hamilton, Anita Clayton
  +4 more sources

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice

Neurology Research International, 2018
Hesperidin, a well-known flavanone glycoside mostly found in citrus fruits, showed neuroprotective and antidepressant activity. Agomelatine, a melatonergic MT1/MT2 agonist and 5-HT2C receptor antagonist, exhibits good antidepressant efficacy.
Jegan Sakthivel Nadar, Pravin Popatrao Kale, Pramod Kerunath Kadu, Kedar Prabhavalkar, Ruchita Dhangar   +4 more
doaj   +1 more source